Tiziana Life Sciences Ltd
TLSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723069
In the last 90 days, Tiziana Life Sciences Ltd insiders filed 4 open-market purchases and 0 sales; 30 institutions reported holding it in 13F filings for Q2 2026, worth $3.10M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Tiziana Life Sciences Ltd changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 23 | 24 | +1 |
| Shares | 5.73M | 5.33M | −396.0K (−6.9%) |
| Value | $6.02M | $3.97M | −$2.05M (−34.0%) |
New holders (3)
Institutions that held Tiziana Life Sciences Ltd at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Zhang Financial LLC | 19,200 | $14.0K | 0.00% |
| BlackRock Inc. | 1,656 | $1.00K | 0.00% |
| Advisor Group Holdings, Inc. | 5 | $0 | 0.00% |
Sold out (2)
Institutions that held Tiziana Life Sciences Ltd at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| JPMorgan Chase & Co | 86,258 | $91.0K |
| Bank of Montreal | 25,000 | $30.0K |